Background: The hypothalamic-pituitary-gonadal axis is transiently activated during the postnatal months in boys, a phenomenon termed “minipuberty” of infancy, when serum testosterone (T) increases to pubertal levels. Despite high circulating T there are no signs of virilization. We hypothesize that free T as measured in saliva is low, which would explain the absence of virilization. Methods: We measured serum total T and free T in saliva using liquid chromatography-tandem mass spectrometry (LC-MS/MS) in 30 infant boys, aged 1–6 months, and in 12 adolescents, aged 11–17 years. Results: Total serum T in all infants was, as expected, high (172 ± 78 ng/dL) while salivary T was low (7.7 ± 4 pg/mL or 0.45 ± 0.20%). In contrast, salivary T in the adolescents was much higher (41 ± 18 pg/mL or 1.3 ± 0.36%) in relation to their total serum T (323 ± 117 ng/dL). We provide for the first time reference data for salivary T in infants. Conclusion: Measurement of salivary T by LC-MS/MS is a promising noninvasive technique to reflect free T in infants. The low free T explains the absence of virilization. The minipuberty of infancy is more likely of intragonadal than peripheral significance.

Keywords:
Minipuberty, Salivary testosterone, Infants
1.
Chada M, Prusa R, Bronsky J, Kotaska K, Sidlova K, Pechova M, et al: Inhibin B, follicle stimulating hormone, luteinizing hormone and testosterone during childhood and puberty in males: changes in serum concentrations in relation to age and stage of puberty. Physiol Res 2003;52: 45–51.
2.
Forest MG, Sizonenko PC, Cathiard AM, Bertrand J: Hypophyso-gonadal function in humans during the first year of life. 1. Evidence for testicular activity in early infancy. J Clin Invest 1974;53: 819–828.
3.
Andersson AM, Toppari J, Haavisto AM, Petersen JH, Simell T, Simell O, et al: Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998;83: 675–681.
4.
Cortes D, Muller J, Skakkebaek NE: Proliferation of Sertoli cells during development of the human testis assessed by stereological methods. Int J Androl 1987;10: 589–596.
5.
Boas M, Boisen KA, Virtanen HE, Kaleva M, Suomi AM, Schmidt IM, et al: Postnatal penile length and growth rate correlate to serum testosterone levels: a longitudinal study of 1962 normal boys. Eur J of Endocrinol 2006;154: 125–129.
6.
de Ronde W, van der Schouw YT, Pierik FH, Pols HA, Muller M, Grobbee DE, et al: Serum levels of sex hormone-binding globulin (SHBG) are not associated with lower levels of non-SHBG-bound testosterone in male newborns and healthy adult men. Clin Endocrinol 2005;62: 498–503.
7.
Matsui F, Koh E, Yamamoto K, Sugimoto K, Sin HS, Maeda Y, et al: Liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for simultaneous measurement of salivary testosterone and cortisol in healthy men for utilization in the diagnosis of late-onset hypogonadism in males. Endocr J 2009;56: 1083–1093.
8.
Forest MG, Cathiard AM, Bertrand JA: Total and unbound testosterone levels in the newborn and in normal and hypogonadal children: use of a sensitive radioimmunoassay for testosterone. J Clin Endocrinol Metab 1973;36: 1132–1142.
9.
Huhtaniemi I, Dunkel L, Perheentupa J: Transient increase in postnatal testicular activity is not revealed by longitudinal measurements of salivary testosterone. Pediatr Res 1986;20: 1324–1327.
10.
Cho H, Sanayama K, Sasaki N, Nakajima H: Salivary testosterone concentration and testicular volume in male infants. Endocrinol Jpn 1985;32: 135–140.
11.
Thienpont LM, Van Uytfanghe K, Blincko S, Ramsay CS, Xie H, Doss RC, et al: State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry. Clin Chem 2008;54: 1290–1297.
12.
Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H: Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007;92: 405–413.
13.
Keevil BG, MacDonald P, Macdowall W, Lee DM, Wu FC: Salivary testosterone measurement by liquid chromatography tandem mass spectrometry in adult males and females. Ann Clin Biochem 2014;51: 368–378.
14.
Bolton NJ, Tapanainen J, Koivisto M, Vihko R: Circulating sex hormone-binding globulin and testosterone in newborns and infants. Clin Endocrinol 1989;31: 201–207.
15.
Chemes HE: Infancy is not a quiescent period of testicular development. Int J Androl 2001;24: 2–7.
16.
Cassorla FG, Golden SM, Johnsonbaugh RE, Heroman WM, Loriaux DL, Sherins RJ: Testicular volume during early infancy. J Pediatr 1981;99: 742–743.
17.
O’Shaughnessy PJ, Morris ID, Huhtaniemi I, Baker PJ, Abel MH: Role of androgen and gonadotrophins in the development and function of the Sertoli cells and Leydig cells: data from mutant and genetically modified mice. Mol Cell Endocrinol 2009;306: 2–8.
18.
Ivell R, Heng K, Anand-Ivell R: Insulin-like factor 3 and the HPG axis in the male. Front Endocrinol 2014;5: 6.
19.
Griffeth RJ, Bianda V, Nef S: The emerging role of insulin-like growth factors in testis development and function. Basic Clin Androl 2014;24: 12.
20.
Bulldan A, Dietze R, Shihan M, Scheiner-Bobis G: Non-classical testosterone signaling mediated through ZIP9 stimulates claudin expression and tight junction formation in Sertoli cells. Cell Signal 2016; 28: 1075–1085.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.